Cargando…

APOEε4 and risk of Alzheimer’s disease – time to move forward

The inheritance of Apolipoprotein E4 (APOEε4) brings the highest genetic risk of Alzheimer’s disease (AD), arguably the highest genetic risk in human pathology. Since the discovery of the association, APOE protein isoforms have been at the center of tens of thousands of studies and reports. While, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lefterov, Iliya, Fitz, Nicholas F., Lu, Yi, Koldamova, Radosveta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235508/ https://www.ncbi.nlm.nih.gov/pubmed/37274212 http://dx.doi.org/10.3389/fnins.2023.1195724

Ejemplares similares

The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives
por: Wolfe, Cody M., et al.
Publicado: (2018)

Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
por: Fitz, Nicholas F., et al.
Publicado: (2020)

Small nucleolar RNAs in plasma extracellular vesicles and their discriminatory power as diagnostic biomarkers of Alzheimer’s disease
por: Fitz, Nicholas F., et al.
Publicado: (2021)

Genome-wide alteration of histone methylation profiles associated with cognitive changes in response to developmental arsenic exposure in mice
por: Fitz, Nicholas F., et al.
Publicado: (2022)

Memory deficits in APP23/Abca1(+/−) mice correlate with the level of Aβ oligomers
por: Lefterov, Iliya, et al.
Publicado: (2009)

ABCA1 haplodeficiency affects the brain transcriptome following traumatic brain injury in mice expressing human APOE isoforms
por: Castranio, Emilie L., et al.
Publicado: (2018)

Extracellular Vesicles in Young Serum Contribute to the Restoration of Age-Related Brain Transcriptomes and Cognition in Old Mice
por: Fitz, Nicholas F., et al.
Publicado: (2023)

Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice
por: Carter, Alexis Y., et al.
Publicado: (2017)

APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain
por: Lefterov, Iliya, et al.
Publicado: (2019)

Multi-transcriptomics reveals brain cellular responses to peripheral infection in Alzheimer’s disease model mice
por: Lu, Yi, et al.
Publicado: (2023)

RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers
por: Nam, Kyong Nyon, et al.
Publicado: (2016)

Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer’s disease
por: Fitz, Nicholas F., et al.
Publicado: (2021)

ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice
por: Fitz, Nicholas F., et al.
Publicado: (2017)

Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment
por: Lefterov, Iliya, et al.
Publicado: (2007)

Genome-Wide Alteration of Histone H3K9 Acetylation Pattern in Mouse Offspring Prenatally Exposed to Arsenic
por: Cronican, Andrea A., et al.
Publicado: (2013)

Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Disease
por: Mishra, Aarti, et al.
Publicado: (2018)

Effect of high fat diet on phenotype, brain transcriptome and lipidome in Alzheimer’s model mice
por: Nam, Kyong Nyon, et al.
Publicado: (2017)

APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease
por: Hou, Min, et al.
Publicado: (2021)

Midlife Lifestyle Activities Moderate APOE ε4 Effect on in vivo Alzheimer’s Disease Pathologies
por: Jeon, So Yeon, et al.
Publicado: (2020)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
por: Sánchez-Juan, Pascual, et al.
Publicado: (2019)

Obesity reduces hippocampal structure and function in older African Americans with the APOE-ε4 Alzheimer’s disease risk allele
por: Osiecka, Zuzanna, et al.
Publicado: (2023)

A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer’s Disease
por: Jiang, Shan, et al.
Publicado: (2016)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

The APOE(ε3/ε4) Genotype Drives Distinct Gene Signatures in the Cortex of Young Mice
por: Foley, Kate E., et al.
Publicado: (2022)

Association of APOE ε4/ε4 with fluid biomarkers in patients from the PUMCH dementia cohort
por: Shang, Li, et al.
Publicado: (2023)

Leisure Activities, APOE ε4, and Cognitive Decline: A Longitudinal Cohort Study
por: Zhang, Yun, et al.
Publicado: (2021)

Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease
por: Caesar, Ina, et al.
Publicado: (2012)

A brain proteomic signature of incipient Alzheimer’s disease in young APOE ε4 carriers identifies novel drug targets
por: Roberts, Jackson A., et al.
Publicado: (2021)

APOEε4 associates with microglial activation independently of Aβ plaques and tau tangles
por: Ferrari-Souza, João Pedro, et al.
Publicado: (2023)

APOE ε4 allele, along with G206D-PSEN1 mutation, alters mitochondrial networks and their degradation in Alzheimer’s disease
por: Costa-Laparra, Irene, et al.
Publicado: (2023)

Alzheimer's disease genetic risk variants beyond APOE ε4 predict mortality
por: Mez, Jesse, et al.
Publicado: (2017)

Rate of brain aging and APOE ε4 are synergistic risk factors for Alzheimer’s disease
por: Glorioso, Christin A, et al.
Publicado: (2019)

Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele
por: Roberts, Rosebud O., et al.
Publicado: (2015)

The Effects of rs405509 on APOEε4 Non-carriers in Non-demented Aging
por: Wu, Dongpeng, et al.
Publicado: (2021)

The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores
por: Stocker, Hannah, et al.
Publicado: (2018)

APOE ε4, an Alzheimer’s disease susceptibility allele, and smoking cessation
por: Ashare, Rebecca L., et al.
Publicado: (2012)

Age‐dependent effects of APOE ε4 in preclinical Alzheimer's disease
por: Bonham, Luke W., et al.
Publicado: (2016)

Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis
por: Momkute, Liucija, et al.
Publicado: (2022)

Differences in resting state functional connectivity underlie visuomotor performance declines in older adults with a genetic risk (APOE ε4) for Alzheimer’s disease
por: Rogojin, Alica, et al.
Publicado: (2022)

Corrigendum: The Effects of rs405509 on APOEε4 Non-carriers in Non-demented Aging
por: Wu, Dongpeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_40tgcb0k7on6klq3lbh0sbjujf